The SIRT3 arm molecular signature of the UPRmt was recently shown to contribute to breast cancer invasiveness and may be an essential mechanism for cancer cells to adapt to proteotoxic and mitochondrial stress, a process called mitohormesis [48]. Here, SIRT3 is linked to breast carcinoma.